ATN classification and clinical progression in subjective cognitive decline
Jarith L. Ebenau(MACOM (United States)), Wiesje M. van der Flier(Amsterdam Neuroscience), Pieter Jelle Visser(Karolinska Institutet), Rosalinde E.R. Slot(MACOM (United States)), Sander C.J. Verfaillie(Amsterdam UMC Location VUmc), Niels D. Prins, Bart N.M. van Berckel(Amsterdam Neuroscience), Anouk den Braber(Max Planck Institute for Psycholinguistics), Karlijn A. van den Bosch(MACOM (United States)), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Inge M.W. Verberk(Amsterdam Neuroscience), Sietske A.M. Sikkes(Amsterdam Neuroscience), Tessa Timmers(MACOM (United States)), Charlotte E. Teunissen(Amsterdam Neuroscience), Linda M.P. Wesselman(MACOM (United States)), Jori Tomassen(MACOM (United States)), Argonde C. van Harten(Amsterdam Neuroscience), Mardou van Leeuwenstijn(Amsterdam Neuroscience), Philip Scheltens(Amsterdam University Medical Centers)
Cited by 200
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k